http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103613626-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-213 |
| filingDate | 2013-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103613626-B |
| titleOfInvention | A kind of adenosine cyclophosphate compound and meglumine adenosine cyclophosphate medicine composition thereof |
| abstract | The present invention relates to a kind of adenosine cyclophosphate compound and meglumine adenosine cyclophosphate medicine composition thereof.Adenosine cyclophosphate compound of the present invention is crystal, adopt X-ray powder diffraction to measure, in its collection of illustrative plates, characteristic peak ° is 5.8 °, 6.9 °, 7.6 °, 11.3 °, 16.5 °, 19.2 °, 21.7 °, 22.6 °, 24.0 °, 25.9 °, 30.1 °, 31.2 °, 33.4 ° displays in 2 θ ± 0.2.The present invention also provides effective constituent to be the injection liquid of adenosine cyclophosphate compound of the present invention and meglumine adenosine cyclophosphate composition injection and Meglumine Adenosine Cyelophosphate dextrose composition injection liquid thereof.Cyclic AMP injecta of the present invention compared to existing technology stability is significantly increased, and adds L MALIC ACID, sodium tartrate can improve stability further in prescription. |
| priorityDate | 2013-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.